Literature DB >> 6165278

Sensitivity of human ovarian carcinoma cells to interferon and other antitumor agents as assessed by an in vitro semi-solid agar technique.

L B Epstein, J T Shen, J S Abele, C C Reese.   

Abstract

To determine the sensitivity in vitro of human ovarian carcinoma cells to the antiproliferative effects of human leukocyte interferon, 18 samples of ascitic fluid from 15 affected patients were cultured in semi-solid agar by the technique of Hamburger and Salmon. Cultures were examined at weekly intervals after initiation and the number and size of each tumor colony recorded. Growth as defined by increase in total tumor colony number with time was obtained in 45% of the samples, or 53% of the patients, or 67% of the ascitic fluid samples with tumor cells demonstrated by Pap smear. No growth occurred in samples from recently treated patients or in samples devoid of tumor cells as assessed by Pap smear. Response to interferon directly incorporated into the agar culture system or preincubated with cells prior to their inclusion in culture was defined as reduction in total colony number by greater than or equal to 50% and partial response by greater than or equal to 25% reduction. The response rate for samples, The nontreated controls of which showed evidence of growth, was 71%, and that of samples that contained tumor colonies with no increase in growth during the culture period was 75%. Sensitivity to interferon was not related to the histology or grade of the tumor or to the stage of the disease. In general the responsiveness of the tumor cells to interferon ran parallel to the overall responsiveness to a variety of other chemotherapeutic agents. As this culture system has been proven by other investigators to be predictive of in vivo resistance to antitumor drugs with considerable accuracy and also to be predictive of in vivo response to a lesser degree, it will be important to determine whether similar relationships between in vitro and in vivo sensitivity obtain for interferon.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6165278     DOI: 10.1111/j.1749-6632.1980.tb20624.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  12 in total

1.  Antiproliferative effect of interferons on human prostate carcinoma cell lines.

Authors:  G Sica; L Fabbroni; L Castagnetta; M Cacciatore; M Pavone-Macaluso
Journal:  Urol Res       Date:  1989

2.  Sensitivity of fresh and cultured ovarian tumor cells to tumor necrosis factor, interferon-alpha 2, and OK-432.

Authors:  Y Nio; J Zighelboim; J S Berek; B Bonavida
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

3.  Effect of fibroblast interferon on colony tumor growth of miscellaneous solid human tumors.

Authors:  P Schlag; J Wolfrum; W Schreml; C Herfarth
Journal:  Klin Wochenschr       Date:  1982-12-01

4.  Direct and indirect effects of human interferon alpha on renal cell carcinoma: a new in vitro assay system for evaluating cytokine-mediated antitumor effects.

Authors:  H Matsuyama; S Yoshihiro; Y Ohmoto; N Yamamoto; K Naito
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

5.  Review of experience with interferon and drug sensitivity testing of ovarian carcinoma in semisolid agar culture.

Authors:  L B Epstein; S G Marcus
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

6.  Activity of human leukocyte interferon in a human tumor cloning system.

Authors:  D D Von Hoff; J Gutterman; B Portnoy; C A Coltman
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

7.  Influence of interferon on the growth of primary ovarian carcinoma cells in a semi-solid agar system: comparison with clinical effects of interferon therapy.

Authors:  P Ling; S Einhorn; I M Anjegård; G Brenning; N Einhorn; H Strander
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

8.  Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assay.

Authors:  M S Aapro; D S Alberts; S E Salmon
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

Review 9.  Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer.

Authors:  Aramide O Lawal; Alfred Musekiwa; Liesl Grobler
Journal:  Cochrane Database Syst Rev       Date:  2013-06-06

Review 10.  Biologic response modifiers in gynecologic malignancies.

Authors:  J P Dutcher; S Wadler; P H Wiernik
Journal:  Yale J Biol Med       Date:  1988 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.